Lacdayeng, Jack Cyves .

HRN: 29-01-76  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/20/2026
06/27/2026
IV
28mg
Q8
PCAP
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  PneumoniaURTIBloodstreamProphylaxis    Compliance to guidelines: Compliant To Guidelines